Former Health Minister and Rajya Sabha member Dr Anbumani Ramadoss has requested the government to consider traditional Indian medicines for treating COVID-19 patients.
"As a western medical practitioner, I do not see anything wrong in it. When COVID-19 was at the highest level, China used traditional Chinese medicine with western medicine," Anbumani said in a statement.
Anbumani further said the traditional Indian medicine has been helpful to cure and prevent dengue, malaria among others.
"At the same time, there has been a misconception about Siddha among some officials. It has to be changed and the central and state governments should pursue it to control the spread of the pandemic," Anbumani said.
The total number of coronavirus cases in India has climbed to 1965 on Thursday, said the Ministry of Health and Family Welfare.
It was reported on January 28 earlier this year that a Siddha doctor from Tamil Nadu claimed to have formulated a herbal medicine that can cure coronavirus.
Dr Thanikasalam Veni of Rathna Siddha Hospital in Chennai has 25-year of vast experience in field Siddha and Ayurvedic medicines.
Speaking to ANI, he had said: "We have formulated a medicine from an extract of herbs. It is very effective to cure any type of viral fever. Coronavirus has no medicine."
"Our herbal extract medicine is used to treat dengue, multi-organ fever and acute liver fever... our medicine is very effective in treating multi-organ failure in corona fever condition," he said.
The Siddha doctor claimed that the medicine formulated by him along with his team treats infections caused by the virus within 24 to 40 hours.
"When we treated the dengue virus with our medicine, many patients with reduced platelets count, acute liver failure, immunity deficiency and low white blood cell (WBC) were cured within 24-40 hours," said Dr Veni.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
